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Abstract Brain and spinal injury reduce mobility and often impair sensorimotor processing in the
spinal cord leading to spasticity. Here, we establish that complete transection of corticospinal
pathways in the pyramids impairs locomotion and leads to increased spasms and excessive mono-
and polysynaptic low threshold spinal reflexes in rats. Treatment of affected forelimb muscles with
an adeno-associated viral vector (AAV) encoding human Neurotrophin-3 at a clinically-feasible time-
point after injury reduced spasticity. Neurotrophin-3 normalized the short latency Hoffmann reflex
to a treated hand muscle as well as low threshold polysynaptic spinal reflexes involving afferents
from other treated muscles. Neurotrophin-3 also enhanced locomotor recovery. Furthermore, the
balance of inhibitory and excitatory boutons in the spinal cord and the level of an ion co-
transporter in motor neuron membranes required for normal reflexes were normalized. Our
findings pave the way for Neurotrophin-3 as a therapy that treats the underlying causes of
spasticity and not only its symptoms.
DOI: 10.7554/eLife.18146.001
Introduction
Up to 78% of patients with spinal cord injury develop spasticity within the first year (Adams and
Hicks, 2005). Spasticity is defined as a velocity-dependent increase in tonic stretch reflexes with
exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflex, and intermittent or
sustained involuntary activation of muscles (Pandyan et al., 2005). Current treatments like tizani-
dine, botulinum toxin and baclofen are only symptomatic, transiently effective and have varying side
effects (Adams and Hicks, 2005; Thibaut et al., 2013). These symptomatic treatments, which aim at
exaggerated reflexes and muscle tone, rarely improve other functional disabilities associated with
upper motor neuron lesions such as overground locomotion (Dietz and Sinkjaer, 2007). There has
been progress in understanding the potential underlying causes of spasticity. However, it remains
challenging to model spastic behaviours in rodents. Models are needed to identify new candidate
therapies for spasticity. Upper arm spasticity after spinal cord injury and stroke often persists and
hampers rehabilitation and effective new therapies are badly needed (Dietz and Fouad, 2014;
Adams and Hicks, 2005).
To date, spastic behaviours that have been examined in rat models include tail spasms and clonus
(Bennett et al., 2004, 1999) and spontaneous hindlimb and tail spasms during swimming
(Gonzenbach et al., 2010). One main goal of our study was to model a variety of signs of forelimb
Kathe et al. eLife 2016;5:e18146. DOI: 10.7554/eLife.18146 1 of 30
RESEARCH ARTICLE
spasticity in awake, freely moving rats. These signs include clonus (repeated muscle jerks), prolonged
spasms, twitches (fast involuntary contractions) and hyperreflexia, which reflect all symptoms associ-
ated with human spasticity after upper motor neuron lesions.
We sought to understand the mechanisms underlying these functional sensorimotor abnormali-
ties. Sensory inputs from muscles spindles to the spinal cord play a major role in regulating spinal
motor circuitry organization and output, especially after CNS injury (Takeoka et al., 2014;
Akay et al., 2014). Group I and II proprioceptive afferents innervating muscle spindles project via
the dorsal root ganglia (DRG) into the spinal cord to synapse onto motor neurons or interneurons
whilst Ib afferents from Golgi tendon organs form synapses on interneurons only (Eccles et al.,
1957; Dietz, 2002). The spinal circuitry integrating these sensory signals has a highly specific pat-
terning in order to produce complex muscle activation synergies (Kiehn, 2016). Proprioceptive neu-
rons provide positive feedback about muscle contractions, which adjusts movements to
environmental factors and controls reflex responses via monosynaptic and polysynaptic spinal path-
ways (Dietz, 2002).
After traumatic brain or spinal cord injury, the circuits below the lesion site lose some supraspinal
input, but they can reorganize and adapt. This reorganization can involve maladaptation causing
functional abnormalities such as spasticity. Proposed mechanisms of spasticity include increased
activity and connectivity between proprioceptive Ia muscle afferents and motor neurons, reduced
presynaptic inhibition of Ia afferents by spinal interneurons (Toda et al., 2014; Kakinohana et al.,
2012), reduced autogenic inhibition from Golgi tendon organs (via Ib afferents and inhibitory inter-
neurons), reduced reciprocal inhibition by Ia afferents from antagonist muscles and modified excita-
tion and inhibition from muscle spindle group II afferents reviewed in [Nielsen et al., 2007;
eLife digest Injuries to the brain and spinal cord cause disability in millions of people
worldwide. Physical rehabilitation can restore some muscle control and improve mobility in affected
individuals. However, no current treatments provide long-term relief from the unwanted muscle
contractions and spasms that affect as many as 78% of people with a spinal cord injury. These
spasms can seriously hamper a person’s ability to carry out day-to-day tasks and get around
independently. A few treatments can help in the short term but have side effects; indeed while
Botox injections are used to paralyse the muscle, these also reduce the chances of useful
improvements. As such, better therapies for muscle spasms are needed; especially ones that reduce
spasms in the arms.
Rats with injuries to the spinal cord between their middle to lower back typically develop spasms
in their legs or tail, and rat models have helped scientists begin to understand why these involuntary
movements occur. Now, Kathe et al. report that cutting one specific pathway that connects the
brain to the spinal cord in anesthetised rats leads to the development of spasms in the forelimbs as
well. Several months after the surgery, the rats had spontaneous muscle contractions in their
forelimbs and walked abnormally. Further experiments showed that some other neural pathways in
the rats became incorrectly wired and hyperactive and that this resulted in the abnormal
movements.
Next, Kathe et al. asked whether using gene therapy to deliver a protein that is required for
neural circuits to form between muscles and the spinal cord (called neurotrophin-3) would stop the
involuntary movements in the forelimbs. Delivering the gene therapy directly into the forelimb
muscles of the disabled rats a day after their injury increased the levels of neurotrophin-3 in these
muscles. Rats that received this treatment had fewer spasms and walked better than those that did
not. Further experiments confirmed that this was because the rats’ previously hyperactive and
abnormally wired neural circuits became more normal after the treatment.
Together these results suggest that neurotrophin-3 might be a useful treatment for muscle
spasms in people with spinal injury. There have already been preliminary studies in people showing
that treatment with neurotrophin-3 is safe and well tolerated. Future studies are needed to confirm
that it could be useful in humans.
DOI: 10.7554/eLife.18146.002
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Dietz, 2002]) as well as intrinsic changes in motor neurons such as altered ion channels, serotonergic
receptors and transporter concentrations in the membranes (Boulenguez et al., 2010;
Murray et al., 2011) and an increase in persistent inward currents in motor neurons
(Hultborn et al., 2013; Boulenguez et al., 2010; Bennett et al., 2001; ElBasiouny et al., 2010)
which together cause an increase in motor neuron excitability.
Peripherally derived Neurotrophin-3, a nerve growth factor, is required for survival of large diam-
eter sensory neurons and motor neurons (Ernfors et al., 1994; Woolley et al., 2005) and for correct
patterning of central proprioceptive afferents during development (Patel et al., 2003). Neurotro-
phin-3 can also reduce motor neuron excitability (Petruska et al., 2010). For these reasons, we
elected to evaluate Neurotrophin-3 as a novel therapy for forelimb spasticity in adult rats after upper
motor neuron lesions.
After ensuring the survival and patterning of sensory and motor circuitry during development,
Neurotrophin-3 levels drop in the muscle (Murase et al., 1994). Interestingly, Neurotrophin-3 levels
are again increased after exercise (Go´mez-Pinilla et al., 2001; Ying et al., 2003), such as after reha-
bilitative training post-stroke or spinal cord injury (Hutchinson et al., 2004; Coˆte´ et al., 2011). Reha-
bilitative training which is based on the principle that coordinated afferent input and motor output
improves functional recovery (Frigon and Rossignol, 2006; Rossignol et al., 2006; Smith et al.,
2006) also normalises proprioceptive reflexes in spinal cord injury models (Coˆte´ et al., 2011). Input
from muscle afferents is important for maintaining normal locomotion in adult mice (Akay et al.,
2014) and for the reorganization of supraspinal pathways after spinal cord injury (because genetic
deletion of muscle spindles leads to poorer outcomes [Takeoka et al., 2014]). Neurotrophin-3 is syn-
thesized by muscle spindles in the periphery (Copray and Brouwer, 1994). Therefore, Neurotro-
phin-3 may serve as a muscle-derived signal that enhances functional recovery and neuroplasticity
after spinal cord injury and peripheral supplementation of Neurotrophin-3 might enhance recovery.
Recent studies from our group show that peripherally administered Neurotrophin-3 can remodel
spared corticospinal tract connections and promote sensorimotor recovery in adult and elderly rats
after stroke (Duricki et al., 2016). Peripheral treatment with recombinant Neurotrophin-3 has
already been tested in Phase I and II clinical trials and was found to be safe and well-tolerated
(Parkman et al., 2003; Chaudhry et al., 2000; Coulie et al., 2000; Sahenk, 2007; Sahenk et al.,
2005). Interestingly, Neurotrophin-3 also improved sensory and reflex function in patients with Char-
cot Marie Tooth 1A disease, a large diameter fiber sensorimotor neuropathy (Sahenk et al., 2005).
Taken together, Neurotrophin-3 organizes supraspinal motor tracts and improves sensory function,
but whether spinal sensorimotor circuitry and reflex changes can be regulated by Neurotrophin-3 in
neuromotor disorders has not been demonstrated yet.
Here, we established a novel rodent model of spasticity which displays many aspects of functional
spasticity observed in humans. The model involves bilateral corticospinal tract lesioning in the pyra-
mids, which was sufficient to elicit changes in the connectivity of proprioceptive afferents to motor
neurons resulting in signs of spasticity including hyperreflexia of mono- and polysynaptic reflexes.
Intramuscular overexpression of Neurotrophin-3 normalized several spinal reflexes. Analysis of neu-
rophysiological properties of the spinal circuitry and of molecular markers revealed that Neurotro-
phin-3 acts as a regulator of afferent input connectivity to spinal motor circuitry and as a regulator of
motor neuron excitability. Taken together, our study established that proprioceptive afferent input
strength and connectivity to the spinal cord changes after supraspinal injury, which affected motor
output resulting in signs of spasticity and reduced functional recovery. Overexpression of Neurotro-
phin-3 in the muscles regulated afferent input specificity and re-balanced excitatory and inhibitory
networks in the spinal cord improving functional and neurophysiological outcomes.
Results
Rats developed spasticity after bilateral pyramidotomy
To establish a rodent model of spasticity of the forelimb, we performed a bilateral transection of the
pyramids in the brainstem (bPYX) of anesthetized rats, which interrupts the corticospinal tracts
(Figure 1A–C; Figure 1—figure supplement 1; Figure 2—figure supplement 1). The lesion com-
pleteness was assessed for all rats at the end of the study with eriochrome cyanine staining of the
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Figure 1. Bilateral transection of the corticospinal tracts in the pyramids resulted in forelimb spasms, impaired walking and caused hyperreflexia.
(A) Schematic of experimental set-up. Rats received a bilateral pyramidotomy (bPYX) and were treated 24 hr post-injury with AAV1-NT3 or AAV1-GFP
injections into biceps brachii and distal forelimb flexors and hand muscles. For clarity in describing the consequences of bPYX, Figure 1 shows only
data from uninjured naı¨ve rats and from bPYX rats treated with AAV1-GFP (bPYX GFP). (B) Transverse sections of the medullary brainstem were stained
with eriochrome cyanine to quantify the cross-sectional area of the pyramids in (upper panel) uninjured naı¨ve rats and (lower panel) bPYX GFP rats.
Figure 1 continued on next page
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medulla, which confirmed that corticospinal tract fibers running ventrally through the pyramids had
been cut (Figure 1B; Figure 2—figure supplement 1).
Twenty four hours after injury, rats were randomized to treatment with AAV1 encoding either
human Neurotrophin-3 or GFP (see below). In the first part of this paper, we describe the forelimb
spasticity, other behavioural deficits and changes in spinal reflexes that were observed in rats with
bilateral pyramidotomies (and treated with AAV-GFP) compared to uninjured naı¨ve rats. In the sec-
ond part, we describe how Neurotrophin-3 treatment reduced spasticity, and normalised reflexes,
which was accompanied by anatomical changes and behavioural recovery.
Behaviourally, rats with bilateral pyramidotomy developed spasticity in their forelimbs within two
weeks of injury (Compare Video 1 which shows an uninjured naı¨ve rat which exhibited no spasticity
with Video 2 and 3). The joint movements of the forelimb appeared rigid and the trajectories of the
limb were often changed during the swing phase. Rats had narrow stepping with frequently crossed
placement of their forepaws. During the loading response of the stance phase we observed vertical
oscillatory-like movements, which resulted in bounce-like stepping. Rats displayed spontaneous
Figure 1 continued
Pyramids are absent in the lower panel. Scale bar: 200 mm. (C) The left and right pyramids were almost completely absent in bPYX GFP rats versus
uninjured naı¨ve rats (RM two-way ANOVA, group F = 107.4, p<0.0001; bPYX GFP versus naı¨ve p<0.001). (D) A greater percentage of bPYX GFP rats
exhibited flexor spasms than the percentage that exhibited extensor spasms two weeks post-injury. (E) Rats showed abnormal forelimb movements and
signs of spasticity in the open field after bPYX (RM two-way ANOVA, group F = 19.8, p<0.001; bPYX GFP baseline versus all post-injury Weeks, paired
t-test p-values<0.05). (F) Bilateral pyramidotomy caused rats to make many errors on the horizontal ladder with their treated forelimb as a percentage
of the total steps taken (RM two-way ANOVA, group F = 123.4, p<0.001; bPYX GFP vs naı¨ve p<0.0001; bPYX GFP vs naı¨ve at Weeks 2, 4, 6, 8 and 10,
p-values<0.05). (G) Unilateral Grip Strength Test. bPYX rats had reduced grip strength with their treated forepaw at Weeks 2, 4, 6, 8 and 10 versus
uninjured naı¨ves (RM two-way ANOVA, group F = 145.0, p<0.001; bPYX GFP vs naı¨ve p<0.0001; bPYX GFP vs naı¨ve at Weeks 2, 4, 6, 8 and 10,
p-values<0.05). (H) Responses to mechanical stimulation of the treated forepaw were assessed using the automated von Frey test. Bilateral
pyramidotomy caused slight mechanical hypersensitivity (RM two-way ANOVA, group F = 5.2, p=0.019; bPYX GFP vs naı¨ve p = 0.003; bPYX GFP versus
naı¨ve at Week 4 and 8, p-values<0.05) (I) Montoya Staircase Pellet Reaching Test. This test assesses fine motor function of the distal forelimb. The
sucrose pellets that were eaten on the treated side were counted. Bilateral pyramidotomy led to a persistent deficit in dexterity (RM two-way ANOVA,
group F = 100.3, p<0.0001; bPYX GFP vs naı¨ve p<0.0001; bPYX GFP versus naı¨ve at weeks 1, 2, 4, 6, 8 and 10 post-injury p-values<0.0001). (J) Schematic
showing the H-reflex paradigm. The ulnar nerve was stimulated distally and EMGs were recorded from a homonymous hand muscle (abductor digiti
quinti). (K) Frequency-dependent depression: The H-wave was depressed at short inter-stimulus intervals in uninjured naı¨ve rats. Less H-wave
depression was observed in bPYX GFP rats two weeks post injury (RM two-way ANOVA, group F = 9.8, p<0.0001; uninjured versus bPYX GFP at 2 s, 1 s,
0.5 s, 0.2 s and 0.1 s inter-stimulus interval p-values<0.05). (L) Data for each rat at each week was analysed by measuring the area under each curve
which gives an electrophysiological correlate of hyperreflexia. Bilateral pyramidotomy caused an increase in hyperreflexia relative to uninjured naı¨ve rats
at week 2, 4, 6, 8 and 10 (RM two-way ANOVA, group F = 5.9, p<0.001; bPYX GFP versus naı¨ve p = 0.003; bPYX GFP versus naı¨ve at weeks 2, 6 and 10
post-injury, p-values<0.05). (M) At week 10, the radial, median and ulnar nerves were exposed for stimulation and recording. The radial nerve (blue)
innervates extensor muscles (blue) whereas the median and ulnar nerves (pink and magenta) innervate synergist flexor muscles (magenta). (N)
Stimulation of afferents in the median nerve evoked responses in the (synergist, flexor) ulnar nerve. (O–P) Example traces show recordings from (O)
uninjured naı¨ve and (P) bPYX GFP rats. The boxed area highlights polysynaptic compound action potentials which were analysed for Figure 1Q. (Q)
The polysynaptic compound action potentials were quantified by measuring the absolute integral (area under the rectified curve) from 3.5 ms to 12 ms.
bPYX GFP rats had an increased polysynaptic reflex response (one-way ANOVA F-value = 4.8, p=0.02; bPYX GFP versus naı¨ve, p-value = 0.02). (R)
Stimulation of afferents in the radial nerve evoked polysynaptic responses in the (antagonistic) ulnar nerve. (S–T) Representative traces showing
recordings from (S) uninjured naı¨ve and (T) bPYX GFP rats. The boxed area highlights polysynaptic compound action potentials which were analysed for
Figure 1U. (U) The polysynaptic compound action potentials were quantified by measuring the absolute integral (area under the rectified curve) from
3.5 ms to 12 ms. bPYX GFP rats had increased polysynaptic responses versus uninjured naı¨ve rats (one-way ANOVA F-value = 4.2, p=0.03; bPYX GFP
versus naı¨ve, p-value = 0.01). (A–U) n = 10 or 11 per group. Data are represented as mean ± SEM.
DOI: 10.7554/eLife.18146.003
The following figure supplements are available for figure 1:
Figure supplement 1. Lesion cross-sectional areas were similar on the left and right of the medulla.
DOI: 10.7554/eLife.18146.004
Figure supplement 2. Scoring sheet for spasticity and disordered sensori-motor control of the forelimb.
DOI: 10.7554/eLife.18146.005
Figure supplement 3. The H reflex undergoes frequency-dependent depression in uninjured naı¨ve rats whereas this is attenuated in rats with bilateral
pyramidotomy.
DOI: 10.7554/eLife.18146.006
Figure supplement 4. Polysynaptic reflex responses recorded from the radial nerve after ulnar nerve stimulation were not changed after injury.
DOI: 10.7554/eLife.18146.007
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abnormal prolonged muscle contractions
(spasms), and single or repeated muscle jerks
(twitch and clonus respectively) with their fore-
limbs. We observed that spontaneously occurring
spasms were more prevalent in forelimb pro-
gravity (limb flexor) muscles than anti-gravity
(limb extensor) muscles (Figure 1D). Their hindlimbs and tail also displayed signs of spasticity
(Video 3). During the swing phase, rats with bilateral pyramidotomies lifted their hindlimbs higher
than uninjured rats, which may indicate increased hip pro-gravity (flexor) muscle activity. Based on
our observations, we developed a novel open-field scoring system for rats, which measures spasticity
and disordered sensorimotor control of the forelimbs during locomotion and spasticity-associated
reactions (Figure 1—figure supplement 2; compare Video 1 with Video 2). Using this scoring sys-
tem we show that spasticity developed by two weeks and was sustained up until the end of the test-
ing period at 10 weeks after bilateral pyramidotomy (Figure 1E).
To assess skilled locomotor deficits, we tested rats with bilateral pyramidotomies on the horizon-
tal ladder with irregularly spaced rungs. Rats frequently made errors with their forelimbs because of
overstepping or muscle jerks (Figure 1F). Furthermore, forelimb grip strength was reduced
(Figure 1G). Von Frey testing of the forepaw pad revealed very modest mechanical hypersensitivity
after injury (Figure 1H). Dexterity assessed with the Montoya staircase pellet-reaching test was per-
sistently reduced (Figure 1I).
Rats developed exaggerated low threshold spinal reflexes after
bilateral pyramidotomy
To determine the mechanisms whereby bilateral corticospinal tract injury causes spasticity, we
assessed spinal reflex excitability with two electrophysiological paradigms using low intensity nerve
stimulation while rats were anaesthetized. These revealed hyper-excitability of a forelimb H-reflex
and of polysynaptic spinal reflexes in rats with bilateral pyramidotomies.
To measure a proprioceptive Hoffman (H) reflex (Toda et al., 2014) we recorded electromyo-
grams from an affected hand muscle (the abductor digiti quinti) whilst stimulating its ulnar nerve
(Figure 1J). An early M-wave is evoked by motor axon excitation and a later H-wave is evoked by
excitation of Ia afferents synapsing onto motor neurons (Figure 1—figure supplement 3B). The
Video 1. Open-field movements shown by an
uninjured naı¨ve rat (Supplementary to Figure 1 and
Experimental Procedures). Rats are placed in a 50 cm
diameter Plexiglas cylinder and videotaped for 3 min
every fortnight. See Supplementary Figure 1—figure
supplement 2 for scoring system. During swing,
forepaw digits are extended. Joint movements in the
forelimb are smooth and linear. Forepaws are placed
slightly medial to the shoulders and the loading
response in stance phase is normal, i.e. stance initiated
with a single placing movement with immediate weight
bearing. When rearing without wall contact, the rats
regulate their balance fully through the hind-paws and
tail; distal forelimbs are held parallel to the floor.
During swing, hindpaws are not raised above the
lowest point of the belly. Tail twitches are not seen.
DOI: 10.7554/eLife.18146.008
Video 2. Open-field scoring of spasticity and
disordered sensorimotor forelimb movements of rats
with bilateral pyramidotomies (Supplementary to
Figure 1 and Experimental Procedures). Rats exhibiting
signs of disordered sensorimotor control have their
forepaw digits in a flexed position during swing phase
presumably because of hypertonic flexor muscles in the
forepaw. Movements of the wrist, elbow and shoulder
are corrective (swing trajectory is non-linear) and rigid
during swing phase. Stance is narrower compared to
controls, with forepaws aligning rostrocaudally or with
forepaws crossing over. Furthermore, during the
loading response of the stance phase, the forepaw
makes multiple contacts as weight bearing starts
(muscle jerks causing a ’dampened bounce’). Rats
display ’associated reactions’, such as single muscle
jerks, prolonged muscle contractions and repeated
muscle jerks. All these behaviours were scored with the
forelimb scale shown in Figure 1—figure supplement
2. Videos show a number of different rats at a range of
time points after CNS injury.
DOI: 10.7554/eLife.18146.009
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H-wave was often evoked at lower stimulation
intensities than the M-wave, consistent with work
by others (Tan et al., 2012). To confirm that the
putative H-wave is dependent on sensory afferent
stimulation, in three uninjured naı¨ve rat we cut six
ipsilateral cervical dorsal roots, which abolished
the H-wave and did not affect the M-wave (data
not shown). n.b., F-waves are evoked in the rat
only at high stimulation intensities and have very
low amplitudes (Meinck, 1976; Gozariu et al.,
1998).
The forelimb H-reflex paradigm allowed us to
record the H-wave from the same rats prior to
injury and then at multiple times after injury. In
uninjured naı¨ve rats, when two stimuli were deliv-
ered to the ulnar nerve in close succession (for
example using an inter-stimulus interval of 0.5 s)
then the second H wave (coloured red in Fig-
ure 1—figure supplement 3B) was smaller than
the first H wave (coloured grey in Figure 1—fig-
ure supplement 3B), which is known as fre-
quency-dependent-depression. In uninjured rats,
the second H-wave was depressed at inter-stimu-
lus-intervals of 5 s and less (Figure 1K; Figure 1—figure supplement 3B). One day after bilateral
corticospinal tract injury, the H-wave depression was comparable to before injury (Figure 1—figure
supplement 3D). However, at two weeks after bilateral pyramidotomy, the H-wave was less
depressed at intervals less than 5 s (Figure 1K; Figure 1—figure supplement 3C). The attenuation
of H-wave depression at short inter-stimulus intervals lasted at least up to 10 weeks (Figure 1—fig-
ure supplement 3E), which suggests there were long lasting changes in synaptic transmission. Fre-
quency-dependent-depression was assessed fortnightly. We measured the area under the stimulus-
response curve from inter-stimulus intervals of 10 s to 0.1 s (Figure 1—figure supplement 3F) for
each rat at each time point separately and then plotted the group mean values (Figure 1L). Unin-
jured naı¨ve rats showed consistent frequency-dependent depression of the H-wave over 10 weeks,
but injured control rats had reduced frequency-dependent depression from 2 weeks up until the end
of the testing period at 10 weeks (Figure 1L, Table 1), which is evidence for changed synaptic trans-
mission from Ia afferent fibers to motor neurons.
We next determined whether polysynaptic spinal reflexes that can produce compensatory
responses during movement (Dietz, 2002) are also affected by injury. Ten weeks after bilateral corti-
cospinal tract injury, rats were terminally anesthetized and the ulnar, median and radial nerves were
exposed on the treated side (Figure 1M) as described previously (Bosch et al., 2012). We studied
three different reflexes:
Firstly, we recorded from the ulnar nerve whilst stimulating the median nerve (Figure 1N). Both
carry afferents from and innervate synergist forelimb flexor muscles which received AAV injections
(magenta muscles in Figure 1M). Low intensity and low frequency stimulation activates large diame-
ter neurons that include group Ia, Ib and II muscle afferents and group I range skin afferents but not
high threshold ones such as nociceptive C fibers (Brock et al., 1951; Nakatsuka et al., 2000). Low
intensity, low frequency stimulation of the median nerve evoked polysynaptic compound action
potentials in the ulnar nerve in uninjured naı¨ve rats (Figure 1O). They were increased 10 weeks after
bilateral corticospinal tract injury indicating a hyper-excitability of polysynaptic spinal reflexes
(Figure 1P,Q).
Next, we recorded from the ulnar nerve whilst stimulating its antagonistic radial nerve
(Figure 1R). Low intensity and low frequency radial nerve stimulation evoked only very few to no
polysynaptic compound action potentials in the antagonistic ulnar nerve in uninjured naı¨ve rats
(Figure 1S). Ten weeks after bilateral pyramidotomy, polysynaptic compound action potentials were
increased (Figure 1T,U) indicating loss of specificity in afferent connectivity (Figure 6). This gain of
aberrant connectivity may cause increased abnormal co-contraction of antagonists. In summary, after
Video 3. Additional signs and associated features of
spasticity and disordered sensorimotor movements
(Supplementary to Figure 1 and Experimental
Procedures). The behaviours shown in this video were
not scored as part of the forelimb scale, but were
frequently observed. Rats with bilateral pyramidotomy
displayed prolonged forelimb muscle contractions and
repeated muscle jerks when rearing. Furthermore,
stepping with hindlimbs is abnormally high during
swing phases (likely to due to increased activation of
iliopsoas and other hip flexors) and the hindlimb heels
are frequently incompletely placed down. Rats have tail
twitches and are unstable during rearing.
DOI: 10.7554/eLife.18146.010
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bilateral pyramidotomy, stimulation of agonist (median) nerves revealed exaggerated spinal reflexes
in the ulnar nerve (Figure 1M–Q) whilst stimulation of the homonymous (ulnar) nerve revealed exag-
gerated spinal reflexes to a hand flexor muscle (Figure 1J–L). These findings demonstrate spinal
motor circuits of pro-gravity limb flexor muscle groups were hyper-excitable after injury, which is
supported by our behavioural observation that flexor muscles were more likely to be affected by
spasms compared to extensors (Figure 1D).
Lastly, we recorded from the radial nerve while stimulating the ulnar nerve (Figure 1—figure sup-
plement 4A). Low intensity and low frequency ulnar nerve stimulation rarely evoked polysynaptic
compound action potentials in the antagonistic radial nerve in uninjured naı¨ve rats (Figure 1—figure
supplement 4B) and in rats with bilateral pyramidotomy (Figure 1—figure supplement 4C,D). Thus,
we did not observe any or increased reflex activity in the extensor radial nerve after antagonist
(ulnar) stimulation after injury (Figure 1—figure supplement 4). Consistent with this, we seldom
observed spasms in forelimb extensor muscles in freely moving rats (Figure 1D; Video 2). Taken
together, bilateral pyramidotomy led to increased reflexes and muscle spasms primarily involving
flexor muscles.
Table 1. Properties of the M-wave and H-reflex (Supplementary to Figures 1 and 3). Values (mean ± SEM) are given for motor
threshold, M-wave and H-wave latencies and maximum amplitudes, maximum depression of H-wave. The maximum depression of the
H-wave is different between bPYX GFP and bPYX NT3 animals (n = 10 to 11/group, Two-way RM ANOVA, group F = 6.9, p<0.001,
group*week F = 2.3 p = 0.047; post-hoc analysis revealed differences between uninjured naı¨ve rats and bPYX GFP or bPYX NT3 at
Week 2, bPYX GFP and bPYX NT3 or uninjured naı¨ve rats at Week 6, 8 and 10, Fisher’s LSD, p-values *<0.05, **<0.01, ***<0.001,
****<0.0001).
baseline Week 2 Week 4 Week 6 Week 8 Week 10
Motor threshold (mA) naı¨ve 1.14 ± 0.2 2.25 ± 0.5 2.13 ± 0.5 2.01 ± 1.5 2.27 ± 0.4 3.45 ± 0.5
bPYX GFP 1.83 ± 0.3 1.26 ± 0.2 1.71 ± 1.4 2.42 ± 0.5 2.15 ± 0.4 2.05 ± 1.6
bPYX NT3 1.28 ± 0.2 1.33 ± 0.3 2.06 ± 0.4 1.62 ± 0.3 1.79 ± 0.5 2.04 ± 0.5
M-wave latency (ms) naı¨ve 0.96 ± 0.0 0.95 ± 0.1 0.85 ± 0.0 0.88 ± 0.0 0.97 ± 0.1 1.13 ± 0.1
bPYX GFP 0.92 ± 0.1 0.91 ± 0.1 0.98 ± 0.0 0.99 ± 0.1 0.91 ± 0.0 1.01 ± 0.1
bPYX NT3 0.99 ± 0.1 0.89 ± 0.0 1.24 ± 0.3 0.98 ± 0.1 0.94 ± 0.1 1.12 ± 0.1
maximum
M-wave
(mV)
naı¨ve 7.23 ± 0.9 6.76 ± 0.5 5.53 ± 0.4 4.76 ± 0.5 4.83 ± 0.5 3.31 ± 0.4
bPYX GFP 6.34 ± 0.8 6.94 ± 0.9 8.34 ± 0.7 5.84 ± 0.7 6.92 ± 0.6 4.93 ± 0.7
bPYX NT3 7.89 ± 0.8 6.25 ± 0.7 4.82 ± 1.0 6.08 ± 0.7 3.74 ± 0.4 4.32 ± 0.5
H-wave latency
(ms)
naı¨ve 5.66 ± 0.1 5.60 ± 0.1 5.39 ± 0.1 5.42 ± 0.1 5.69 ± 0.1 5.97 ± 0.1
bPYX GFP 5.48 ± 0.1 5.24 ± 0.1 5.67 ± 0.1 5.55 ± 0.4 5.42 ± 0.1 5.60 ± 0.2
bPYX NT3 5.22 ± 0.1 5.30 ± 0.2 5.80 ± 0.3 5.48 ± 0.1 5.36 ± 0.2 5.40 ± 0.1
maximum H-wave (mA) naı¨ve 1.34 ± 0.2 1.46 ± 0.3 1.09 ± 0.2 1.22 ± 0.2 1.31 ± 0.2 0.92 ± 0.2
bPYX GFP 1.60 ± 0.3 3.50 ± 0.7 2.84 ± 0.5 2.48 ± 1.8 2.72 ± 0.6 1.94 ± 0.5
bPYX NT3 2.43 ± 0.5 2.15 ± 0.4 1.53 ± 0.3 2.01 ± 0.3 1.41 ± 0.2 1.63 ± 0.2
maximum H-wave (%) naı¨ve 19.5 ± 8.0 21.7 ± 3.3 19.7 ± 3.5 29.9 ± 6.5 26.5 ± 3.0 31.2 ± 5.8
bPYX GFP 29.5 ± 6.7 46.2 ± 4.7 31.9 ± 4.8 41.8 ± 5.7 40.8 ± 6.2 43.8 ± 5.5
bPYX NT3 30.7 ± 5.7 38.2 ± 6.5 36.8 ± 4.8 44 ± 10.7 45.3 ± 9.1 45.0 ± 8.8
maximum depression
of H-wave
naı¨ve 24.3 ± 4.2 35.9 ± 3.8
****
42.7 ± 6.7 37.9 ± 7.3 34.7 ± 6.6 41.0 ± 5.5
bPYX GFP 38.5 ± 5.9 56.4 ± 7.9 57.5 ± 8.7 61.0 ± 8.c2
***
56.3 ± 8.1
*
62.9 ± 8.3
***
bPYX NT3 37.9 ± 5.9 58.9 ± 6.1 48.6 ± 8.0 37.6 ± 5.8 36.5 ± 6.3 29.2 ± 3.9
Table 1: Properties of the M- and H-wave.
DOI: 10.7554/eLife.18146.011
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Figure 2. Increased levels of neurotrophin-3 in muscle and blood post-injection of AAV1 neurotrophin-3 into forelimb muscles. (A) Schematic showing
experimental set-up. Rats received bilateral pyramidotomies and were injected either AAV1-NT3 or AAV1-GFP into forelimb muscles. The
monosynaptic proprioceptive reflexes are shown. Group Ia afferents project from the muscle via their cell bodies in the DRG into the spinal cord. Motor
neurons project to the muscles. (B) ELISAs confirmed that neurotrophin-3 is upregulated in the biceps brachii 10 weeks post-injection with AAV1-NT3
(n = 10/11 per group, RM two-way ANOVA, group F = 7.2, p = 0.003, post-hoc analysis revealed an increase only on the injected side of the bPYX NT3
group versus naı¨ve or bPYX GFP, p-values<0.05). (C) The Neurotrophin-3 level in the blood serum was also increased after AAV1 NT-3 treatment (one-
way ANOVA, F-value = 3.4, p=0.047, bPYX NT3 versus naı¨ve or bPYX GFP, p-values<0.05). (D) A separate cohort of rats was injected with either AAV1-
GFP or AAV1-NT3 into forelimb muscles. ELISAs of C3 to C8 DRGs showed a 2.3 fold increase of NT3 only in DRGs from the side ipsilateral 4 weeks
after injections (n = 4/5 per group, one-way ANOVA, F = 34.13, p<0.001, AAV-NT3 injected side versus all other groups, p-values<0.05). (E) qRT-PCR
Figure 2 continued on next page
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Intramuscular injection of AAV1-Neurotrophin-3 increased levels of
Neurotrophin-3 protein in treated flexor muscles, ipsilateral cervical
DRG and ipsilateral spinal cord neurons
Twenty four hours after bilateral pyramidotomy, rats were randomized to treatment with AAV1
encoding either human Neurotrophin-3 or GFP, which was injected into many forelimb flexor
muscles (listed in Methods) (Figure 2A). At the end of the study, Enzyme-Linked Immunosorbent
Assays (ELISAs) showed that Neurotrophin-3 protein levels were elevated in treated muscles (e.g., in
the ipsilateral but not contralateral biceps brachii) (Figure 2B) as well as in the blood (Figure 2C).
There was a non-significant trend toward increased Neurotrophin-3 in the ipsilateral triceps brachii
(Figure 2—figure supplement 2) which may have resulted from AAV spread from nearby muscles
(e.g., biceps brachii) during injection or transport in the bloodstream. We did not detect any trend
to an increase contralaterally in muscles (Figure 2, Figure 2—figure supplement 2).
Homogenates of cervical DRGs were used for RNAseq (data not shown) and the spinal cords
were processed for immunohistochemistry (see below). We generated an additional cohort of rats to
measure NT-3 protein levels in cervical DRGs, the spinal cord and other tissues at 4 weeks after
injection of AAV1. ELISA showed that Neurotrophin-3 protein levels were elevated in ipsilateral (but
not contralateral) cervical C3-C8 DRGs (Figure 2D), consistent with retrograde transport of hypo-
thetically either AAV1 particles and/or Neurotrophin-3 protein itself. We found that the AAV1 vector
carrying the transgene was not retrogradely transported to the DRG (Figure 2E). RNA from homo-
genates of cervical DRGs were subjected to qRTPCR using primers that distinguish human Neurotro-
phin-3 mRNA (i.e., transgene specific) from rat Neurotrophin-3 mRNA (i.e., endogenous). Samples
from AAV-NT3 and AAV-GFP groups had CT values 35, comparable to the No Template Control
(water). In other words, we did not detect human Neurotrophin-3 mRNA in the ipsilateral or contra-
lateral cervical DRGs of rats injected with AAV1-NT3 or AAV1-GFP (Figure 2E) although we did
detect a strong signal for human Neurotrophin-3 in positive control samples of human brain cDNA.
Together these results show that the viral vector itself was not retrogradely transported to the DRG,
but the neurotrophin-3 protein itself was.
Intramuscular treatment using AAV1-NT3 in this cohort did not significantly increase levels of
Neurotrophin-3 protein in homogenates of ipsilateral or contralateral spinal cervical hemicords (Fig-
ure 2—figure supplement 2B) or liver (Figure 2—figure supplement 2C) 4 weeks after injection.
We next used a more sensitive method, namely immunolabeling, to see whether Neurotrophin-3
was detectable in neurons of the dorsal or ventral horns of the cervical spinal cord (Figure 2F–J).
Immunolabeling revealed that, in rats treated with AAV1-NT3, Neurotrophin-3 protein was increased
in neurons of the ipsilateral cervical dorsal horn (Figure 2H) and ipsilateral cervical motor neurons
(including in their nuclei) (Figure 2J) relative to AAV1-GFP (Figure 2G,I respectively) but not in con-
tralateral dorsal horn or motor neurons. Together these data are consistent with other studies show-
ing receptor-mediated retrograde transport of Neurotrophin-3 protein from injected muscles in
large diameter sensory neurons and motor neurons (Distefano et al., 1992; Helgren et al., 1997).
Figure 2 continued
for human NT-3 mRNA confirms that the viral vector is not transported retrogradely to the DRG. Human neurotrophin-3 mRNA was detected in positive
control samples (human brain cDNA) and in the standard curve but not detected in the ipsilateral (left) DRGs at 4 weeks after injection of AAV-NT3 or
AAV-GFP (n = 5 per group). The x-axis shows the cycle at which signal rose above background threshold (CT) versus the y-axis which shows the
concentration of human NT-3 cDNA with a standard curve plotted through points of the standard. Samples from AAV-NT3 and AAV-GFP groups had
CT values 35 (comparable to water as No Template Control), indicating absence of human NT-3 mRNA in those samples. (F–J) Transverse cervical
spinal cord sections were immunostained for NT3. There was increased immunoreactivity in dorsal horn neurons (compare H with G) and in the nuclei
of motor neurons in laminae XI (compare J with I) in the AAV-NT3 group versus AAV-GFP group although we did not detect increased levels of NT3
protein in the spinal cord overall, see Figure 2—figure supplement 2. Scale bars 0.5 mm. (B–E) Data are represented as mean ± SEM.
DOI: 10.7554/eLife.18146.012
The following figure supplements are available for figure 2:
Figure supplement 1. Lesion cross-sectional areas were similar on the left and right of the medulla in both bPYX groups.
DOI: 10.7554/eLife.18146.013
Figure supplement 2. No increased levels of neurotrophin-3 in homogenates of triceps brachii, spinal cord or liver after injections of an AAV
expressing neurotrophin-3 into the biceps brachii and other forelimb flexors.
DOI: 10.7554/eLife.18146.014
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Figure 3. Intramuscular Neurotrophin-3 treatment improved functional recovery and reduced spasms after bilateral pyramidotomy. Please note that for
clarity in describing our model of spasticity, Figure 1 contained information from Figure 3 relating to the uninjured naı¨ve and bPYX GFP groups. (A)
Neurotrophin-3 treatment reduced signs of spasticity (RM two-way ANOVA, group F = 19.8, p<0.001; bPYX NT3 versus bPYX GFP at Week 6, 8 and 10,
p-values<0.05). (B) Neurotrophin-3 caused rats to make fewer errors on the horizontal ladder with their treated forelimb as a percentage of the total
steps taken (RM two-way ANOVA, group F = 123.4, p<0.001; bPYX NT3 versus bPYX GFP p<0.0001; bPYX NT3 versus bPYX GFP at Week 6, 8 and 10,
p-values<0.05). (C) Unilateral Grip Strength Test. Neurotrophin-3 treatment slightly improved grip strength of the treated forepaw at 10 weeks (RM two-
way ANOVA, group F = 145.0, p<0.001; bPYX NT3 vs bPYX GFP p = 0.11; bPYX NT3 vs bPYX GFP at Week 10, p-value = 0.026). (D) Cutaneous
mechanical hypersensitivity was not affected by NT3 treatment assessed using the automated von Frey test (RM two-way ANOVA, group F = 5.2
p=0.019; bPYX NT3 versus bPYX GFP p = 0.29). (E) Dexterity was assessed using the staircase test. The two treatment groups were impaired relative to
uninjured naı¨ve rats, and no differences were detected between two treatment groups post-injury (RM two-way ANOVA, group F = 100.3, p<0.0001;
bPYX NT3 versus bPYX GFP p = 0.69) confirming that the corticospinal tract is essential for recovery of fine motor function (Weidner et al., 2001). (F)
Figure 3 continued on next page
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In summary, Neurotrophin-3 protein levels were increased in ipsilateral flexor muscles, ipsilateral cer-
vical DRG and in the ipsilateral spinal cord as well as in blood.
Treatment with Neurotrophin-3 improved functional outcomes after
bilateral pyramidotomy
We assessed the forelimb behaviour of rats treated with either AAV-NT3 or AAV-GFP with our newly
developed open-field scoring system (Figure 3A). Within two weeks after bilateral pyramidotomy
injury both treatment groups developed spasticity in their forelimbs. Neurotrophin-3 treatment led
to a reduction of forelimb spasticity which was still ongoing at 10 weeks post-injury and treatment
(Figure 3A).
To assess locomotor deficits, we tested rats on the horizontal ladder task. Rats with bilateral pyra-
midotomy treated with AAV-GFP frequently missed rungs, but intramuscular Neurotrophin-3 treat-
ment gradually improved precision stepping on the horizontal ladder throughout the 10 weeks
testing period (Figure 3B). Additionally, Neurotrophin-3 treated rats partially recovered grip
strength with their treated forelimb (Figure 3C). Importantly, Neurotrophin-3 did not cause or affect
mechanical hypersensitivity, as expected from human clinical trials (Parkman et al., 2003;
Sahenk, 2007; Chaudhry et al., 2000; Coulie et al., 2000; Sahenk et al., 2005) (Figure 3D). Intra-
muscular AAV-NT3 treatment did not improve recovery on the pellet reaching task after bilateral
pyramidotomy (Figure 3E) which is consistent with the fact that corticospinal injury leads to a persis-
tent deficit in dexterity (Weidner et al., 2001). Taken together, these behavioural results demon-
strate that bilateral pyramidotomy is sufficient to cause spasticity in rodents and that these
symptoms can be improved by treating flexor muscles with Neurotrophin-3. Treatment also resulted
in improved functional recovery of motor behaviour. We next show that NT3 modifies neurophysio-
logical properties of spinal reflexes whose low threshold proprioceptive and cutaneous mechanore-
ceptive afferents and motor neurons are known to express TrkC (Lee et al., 2012; McMahon et al.,
1994).
Neurotrophin-3 normalized spinal reflexes evoked by low intensity
stimulation of nerves containing afferents from injected muscles
As described above, rats showed less H-wave depression at inter-stimulus intervals of 5 s and less
after bilateral pyramidotomy. Intramuscular overexpression of Neurotrophin-3 restored the fre-
quency-dependent depression of the H-wave by 6 weeks post-injury (Figure 3F,G, Table 1), consis-
tent with injection of AAV-NT3 into this hand muscle.
Neurotrophin-3 treatment also modified polysynaptic spinal reflexes involving afferents from
treated muscles. Neurotrophin-3 normalised the exaggerated polysynaptic responses that were
measured in the ulnar nerve after median nerve stimulation (Figure 3I–J; Figure 3—figure
Figure 3 continued
Schematic showing the H-reflex paradigm. The ulnar nerve was stimulated distally and EMGs were recorded from a homonymous hand muscle
(abductor digiti quinti). (G) Graph shows changes over time in hyper-reflexia, measured as the area under the curve of the frequency-dependent
depression (Figure 1—figure supplement 3F). Injury groups had exaggerated reflexes from 2 weeks post-injury, but NT3 treated rats had normal
H-wave depression from 6 weeks onwards. (RM two-way ANOVA, group F = 5.9 p<0.001; bPYX NT3 versus bPYX GFP p = 0.024; bPYX NT3 versus bPYX
GFP at Week 6 and 10, p-values<0.05). (H) At week 10, the radial, median and ulnar nerves were exposed for stimulation and recording. The radial
nerve (blue) innervates extensor muscles (blue) whereas the median and ulnar nerves (pink and magenta) innervate synergist flexor muscles that were
injected with AAV (pink and magenta). (I) Stimulation of afferents in the median nerve evoked responses in the (synergist, flexor) ulnar nerve (J) The
polysynaptic compound action potentials were quantified by measuring the absolute integral (area under the rectified curve) from 3.5 ms to 12 ms.
Neurotrophin-3 treatment restored the exaggerated reflexes to normal (one-way ANOVA F-value = 4.8, p=0.02, bPYX NT3 versus bPYX GFP,
p-values = 0.01) (K) Stimulation of afferents in the radial nerve evoked polysynaptic responses in the (antagonistic) ulnar nerve. (L) The polysynaptic
compound action potentials were quantified by measuring the absolute integral (area under the rectified curve) from 3.5 ms to 12 ms. Neurotrophin-3
treatment did not restore the exaggerated reflexes to normal (one-way ANOVA F-value = 4.2, p=0.03, bPYX NT3 versus bPYX GFP, p-values = 0.63) (A–
L) n = 10 or 11 per group. Data are represented as mean ± SEM.
DOI: 10.7554/eLife.18146.015
The following figure supplement is available for figure 3:
Figure supplement 1. Changes in polysynaptic reflexes after bilateral pyramidotomy and with Neurotrophin-3.
DOI: 10.7554/eLife.18146.016
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supplement 1A). Both nerves carry afferents from and innervate synergist forelimb muscles that
were treated with an AAV1 overexpressing Neurotrophin-3. However, Neurotrophin-3 treated ani-
mals had no reduction of the exaggerated polysynaptic responses recorded in the ulnar nerve after
radial nerve stimulation (Figure 3K–L; Figure 3—figure supplement 1B), consistent with the fact
that only flexor muscles were injected with AAV-NT3 and that proprioceptive afferent fibers in the
radial nerve (supplying extensor muscles) did not receive direct treatment. Finally, Neurotrophin-3
treatment did not modify polysynaptic responses evoked in the radial nerve after stimulation of the
ulnar nerve; these responses did not change after injury either (Figure 3—figure supplement 1C–
D). Taken together, we conclude that intramuscular Neurotrophin-3 treatment normalized low-
threshold spinal reflexes whose afferents were exposed to Neurotrophin-3.
Neurotrophin-3 treatment normalized the inhibitory and excitatory
balance in the spinal cord
We characterised functional aspects of sensorimotor abnormalities and hyperreflexia of the forelimb
after CNS injury as well as how Neurotrophin-3 normalizes these. However, the effects of injury and
treatment on the anatomical and molecular makeup within the spinal cord remained to be under-
stood. By studying markers of excitatory and inhibitory networks within the spinal cord, we found
that Neurotrophin-3 restored these networks to naı¨ve levels.
First, to identify motor neuron groups supplying forelimb flexor and extensor muscles, the ulnar
nerve and radial nerve on the treated side were traced retrogradely with either Cholera Toxin beta
subunit (CTb) or Fast blue, respectively. Transverse sections of the cervical spinal cord were immuno-
labeled for vGluT1 which is located in excitatory boutons of proprioceptive and cutaneous mechano-
sensory axons (Alvarez et al., 2011). In the intact rat, vGluT1 boutons on motor neurons are from
proprioceptive afferents (Stepien et al., 2010; Betley et al., 2009). We determined whether the
number of vGluT1 immunoreactive boutons in close proximity to motor neurons changed after
Figure 4. Neurotrophin-3 treatment restored balance between excitatory and inhibitory causes of spasticity. (A–D) Ia boutons were identified by vGluT1
immunolabelling (green) and motor neurons were traced retrogradely with Fast Blue or Cholera Toxin beta (blue) in (B) uninjured naı¨ve rats, (C) bPYX
GFP rats and (D) bPYX NT3 rats. C8, scale bar: 20 mm. (E) bPYX caused an increase in vGluT1 boutons in close proximity to motor neurons.
Neurotrophin-3 reduced the number of boutons to normal (two-way-ANOVA, group F = 33.5 p<0.001; bPYX GFP versus naı¨ve or bPYX NT3,
p-values<0.05). (F) The number of vGluT1 boutons of afferents from the ulnar nerve (CTb traced) increased on radial but not ulnar motor neurons after
bilateral pyramidotomy, which was normalized with NT3 treatment (RM two-way-ANOVA, group F = 4.6, p = 0.01, motor neurons F = 4.2, p = 0.047;
radial MNs bPYX GFP versus naı¨ve or bPYX NT3, p-values<0.05). (G) Proprioceptive afferent boutons (vGluT1, green) receive pre-synaptic inhibition
from boutons immunopositive for the vesicular GABA transporter (vGAT, red) in (H) uninjured naı¨ve rats, (I) bPYX GFP rats and (J) bPYX NT3 rats. C8
transverse spinal cord sections, scale bar 10 mm. Yellow arrows indicate putative pre-synaptically inhibited vGluT1 synapses. (K) Injury led to a reduction
in vGluT1 boutons receiving presynaptic inhibition whereas NT3 restored levels of presynaptic inhibition (one-way ANOVA, F = 3.6 p = 0.042; bPYX GFP
versus naı¨ve or bPYX NT3, p-values<0.05). (E,F,K) n = 10 or 11 per group. Data are represented as mean ± SEM.
DOI: 10.7554/eLife.18146.017
The following figure supplement is available for figure 4:
Figure supplement 1. The density of inhibitory boutons directly onto motor neurons did not change with injury or neurotrophin-3 treatment.
DOI: 10.7554/eLife.18146.018
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bilateral pyramidotomy (Figure 4A–C). After injury, more vGluT1 boutons were found in close prox-
imity to cervical motor neurons of the ulnar and radial nerves (Figure 4E) which might contribute to
the spasticity we report. To explore the specificity of afferent fibers synapsing onto different motor
neuron pools, we took advantage of the fact that injection of CTb into the ulnar nerve also transgan-
glionically labels predominantly large diameter afferents (Shehab and Hughes, 2011). CTb-immuno-
reactive afferents from the ulnar nerve had more vGluT1 boutons in close proximity to radial motor
neurons (Figure 4F). This suggests aberrant strengthening of excitatory afferent connectivity upon
antagonists which might mediate increased co-contractions.
Synapses from primary afferents onto motor neurons (i.e., proprioceptive afferents) are often
modulated by inhibitory synapses from GABAergic interneurons onto the afferent axon terminals
(Figure 4G) (Fink et al., 2014; Betley et al., 2009). We immunolabeled sections of the cervical spi-
nal cord for vGAT (to label presynaptic inhibitory boutons) and for vGluT1 (Figure 4H–I). Analysis of
z-stack confocal images revealed vGAT immunoreactive boutons in close proximity to vGluT1 immu-
noreactive boutons in the ventral horn. After bilateral pyramidotomy, there were fewer vGAT bou-
tons in close proximity to vGluT1 positive boutons (Figure 4K) suggesting they received less
presynaptic inhibition by GABAergic interneurons. Together, these changes indicate abnormally
increased excitation of motor neurons by agonist and antagonist proprioceptive afferents and
explain the hyper-reflexia, co-contraction and spasms exhibited by rats with bilateral corticospinal
tract injuries.
Intramuscular Neurotrophin-3 normalized the number of excitatory vGluT1 boutons onto ulnar
and radial motor neurons (Figure 4D–E), reduced CTb+ ulnar excitatory boutons near to radial
motor neurons towards the levels seen in uninjured naı¨ve rats (Figure 4F) and increased apparent
Figure 5. Neurotrophin-3 treatment normalised serotonergic innervation of the C7/8 spinal cord and the ion transporter KCC2 in motor neuron
membranes to normal. (A) Representative images of C7/8 spinal cords on the treated side immunolabelled for serotonin in uninjured naı¨ve, bPYX GFP
and bPYX NT3 rats. Scale bar: 1 mm. (B) Serotonergic pixel intensity in Ventral Horn (laminae VII-IX) was increased after injury, but NT3 treatment
restored this to normal levels (RM two-way ANOVA, group*horn interaction F = 3.5 p = 0.037; Ventral Horn bPYX GFP versus naı¨ve or bPYX NT3,
p<0.05). Pixel intensities in the dorsal horn (laminae I-III) did not change. (C–D) KCC2 immunolabeling: methods can be found in Figure 5—figure
supplement 1 The pixel intensity of KCC2 across the plasma membrane of motor neurons was decreased after injury but accumulations of KCC2 were
seen intracellularly (yellow arrows). KCC2 was normalized by NT3 (RM two-way ANOVA, group F = 10.2, p<0.001; bPYX GFP versus naı¨ve or bPYX NT3,
p-values<0.05). Scale bar, 20 mm. (B, D) n = 10 or 11 per group. Data are represented as mean ± SEM.
DOI: 10.7554/eLife.18146.019
The following figure supplement is available for figure 5:
Figure supplement 1. Analysis of KCC2 in the membrane of motor neurons.
DOI: 10.7554/eLife.18146.020
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presynaptic inhibition of vGluT1 boutons to normal levels (Figure 4J–K). We propose these changes
contribute to the normalization of the spinal reflexes described above. The number of vGAT immu-
noreactive inhibitory boutons upon motor neurons which mediate post-synaptic inhibition was not
affected by injury or Neurotrophin-3 treatment (Figure 4—figure supplement 1). Together, these
results indicate that Neurotrophin-3 treatment normalised the balance of excitatory and inhibitory
inputs to motor neurons.
Changes in the serotonergic system can also cause spasticity after spinal cord injury. Complete
transection causes an up-regulation of the constitutively active 5HT2C receptor (Murray et al., 2010)
and incomplete spinal cord injury leaves spared serotonergic fibers in the sensitized spinal cord
(D’Amico et al., 2013) which both can cause spasticity by enhancing persistent inward currents. Cer-
vical spinal cord sections were immunolabeled for serotonin and we measured the pixel intensity in
the dorsal laminae I/II/III and the ventral horn. Corticospinal tract injury resulted in an increase of
serotonergic fiber density in the ventral horn, but not in the dorsal horn; the former was normalized
by Neurotrophin-3 treatment (Figure 5A,B). In the ventral horn, serotonin receptor activity can cause
hyper-excitability of motor neurons by regulating the ion symporter KCC2 (Bos et al., 2013). KCC2,
when located to the membrane, expels chloride- and potassium+ ions to regulate the reversal poten-
tial of GABAA responses; if membrane KCC2 is reduced, motor neurons become hyper-excitable
(Boulenguez et al., 2010). After injury, we found less KCC2 in the membrane of ulnar and radial
motor neurons and more accumulations within the somata (Figure 5C,D). Neurotrophin-3 treatment
translocated KCC2 back to the membrane of both ulnar and radial motor neurons (Figure 5C,D).
In conclusion, we demonstrated that afferent fibre patterning and motor neuron properties, which
both project to muscles, were altered with intramuscular Neurotrophin-3 treatment after bilateral
corticospinal tract injury. We have shown that Neurotrophin-3 normalises mono- and poly-synaptic
low threshold reflexes and leads to improved motor recovery after pyramidotomy lesions.
Discussion
To examine underlying causes of spasticity, we developed a novel rodent model of spasticity, which
displays several features of the human condition. We found that excitatory networks within the spinal
cord were upregulated after bilateral pyramidotomy and proprioceptive afferents had increased tar-
geting of antagonistic motor neurons more than in normal rats. We showed that bilateral pyramidot-
omy caused hyperreflexia, abnormal sensorimotor processing, spasms and clumsiness during
walking. Interestingly, behavioural, neurophysiological and anatomical abnormalities could be dra-
matically improved with delayed intramuscular Neurotrophin-3 treatment, and we showed that Neu-
rotrophin-3 overexpression in the muscle restored accurate patterning of central connectivity and
the amount of KCC2 in the motor neuron membrane which is important for normal excitability.
Bilateral corticospinal tract lesioning is sufficient to cause spasticity
Our rodent model gives evidence that selective and complete lesioning of the corticospinal tract
results in spasticity. From the clinicoanatomic perspective, there is an extensive debate whether
selective pyramidal tract damage (a rare event) is sufficient to cause spastic hemiplegia in humans.
Stroke and spinal cord injury, which may or may not affect the corticospinal tract, very commonly
lead to spasticity (Adams and Hicks, 2005). Spasticity symptoms have sometimes been ascribed to
additional damage to extrapyramidal structures, but a recent extensive review of pathological cases
gives evidence that damage to the pyramidal tracts is sufficient and necessary to cause spastic hemi-
plegia in humans (de Oliveira-Souza, 2015). The classic lesion experiments by Lawrence and
Kuypers revealed the role of the corticospinal tract in motor control in non-human primates
(Lawrence and Kuypers, 1968a, 1968b). A large cohort of macaque monkeys received bilateral cor-
ticospinal tract injuries in the pyramids. While skilled hand function is severely affected by the
lesions, the monkeys were still able to walk and climb shortly after the injury. We re-examined their
original videos (Lemon et al., 2012) and observed clonic movements (their Supplementary Videos 2,
3 and 8), narrowed stance during locomotion (their Supplementary Video 6) and increased flexor
activities in their forelimbs (their Supplementary Video 7) supporting the notion that corticospinal
tract injury is sufficient to produce spastic signs and abnormal locomotion in non-human primates as
well as humans.
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Other groups have modelled spasticity in rodents, which has advanced the understanding of
underlying causes of spasticity and the development of novel potential therapies
(Gonzenbach et al., 2010; Boulenguez et al., 2010; Corleto et al., 2015). After thoracic cord tran-
section or contusion, rats show lower limb spasticity (Coˆte´ et al., 2011; Thompson et al., 1998;
Bose et al., 2002; Corleto et al., 2015; Yates et al., 2008) and after sacral cord transection rodents
displayed tail spasms (Bennett et al., 2004; Kapitza et al., 2012; Murray et al., 2010). A midthora-
cic T-lesion, which essentially damages the dorsomedial, dorsolateral and ventromedial parts of the
corticospinal tracts, results in hindlimb spasms during swimming (Gonzenbach et al., 2010).
Whereas these injuries provide models of hindlimb/tail spasticity, which can be measured after stim-
ulation or during specialized behavioural testing for rats, our model of bilateral pyramidotomy allows
observation of spasticity in the forelimbs, hindlimbs and tail during awake, free movements in the
open field. Our model shows visible signs of spasticity including increased reflexes similar to the
human condition. Our model provides further evidence that exclusive corticospinal tract lesioning is
sufficient to produce signs of spasticity. Our model also has allowed us to identify a new intervention
to treat the underlying neuronal component of disordered sensorimotor control resulting from upper
motor neuron lesions.
Bilateral pyramidotomy causes changes in the pattern of excitatory and
inhibitory boutons in the spinal cord
One of the more potent anti-spasticity drugs is baclofen, a GABAB receptor agonist (Stempien and
Tsai, 2000). Although it may result in adverse systemic side effects and increasing tolerance during
long-term treatment, it is evident that increasing inhibition in the spinal cord is an effective treat-
ment for spasticity. Spasticity is associated with a decrease of inhibitory synapses and inhibitory
post-synaptic potentials in motor neurons (Kapitza et al., 2012; Kakinohana et al., 2012;
Boulenguez et al., 2010) plus concurrent increase of excitatory synapses upon and persistent inward
currents in motor neurons (Tan et al., 2012; Toda et al., 2014; Bennett et al., 2001;
Hultborn et al., 2013). We give evidence that there is an increase of vGluT1 boutons from proprio-
ceptive afferents onto motor neurons and less presynaptic inhibition of proprioceptive afferents in
the cervical spinal cord after bilateral pyramidotomy. We also show increased motor neuron excit-
ability through changes in the ion transporter KCC2, but no change in a marker of inhibitory
GABAergic synapses/boutons as shown by immunolabeling for vGAT near motor neurons (Figures 4,
5, Figure 4—figure supplement 1).
Functionally, knocking out presynaptic GABAergic interneurons results in limb oscillations during
directed reaching for sugar pellets (Fink et al., 2014). Our bilateral pyramidotomy model results in
reduced presynaptic inhibition, oscillatory like movements during the loading response of the stance
phase and oscillatory clonic movements of the forelimb which may result from aberrant spinal proc-
essing of mechanoceptive and proprioceptive inputs (Figures 1, 3, Figure 1—figure supplement 2
and Videos 2 and 3). These oscillations are also seen in the non-human primates with bilateral pyra-
midotomy during reaching for food morsels (Supplementary Videos 2, 3 and 8 in [Lemon et al.,
2012]). Intriguingly, our work indicates that there is not only an increase in excitation (Figure 4), but
also loss of patterning specificity after bilateral pyramidotomy: We observed abnormal monosynap-
tic connectivity to radial motor neurons by afferents from an antagonistic flexor nerve (Figure 4) and
abnormal polysynaptic connectivity to ulnar motor neurons by afferents from the radial nerve (Fig-
ures 1, 3). Anatomically, we showed increased numbers of flexor proprioceptive afferent synapses
onto motor neurons supplying extensor muscles and neurophysiologically, increased connectivity
between flexor and extensor afferents to flexor motor neurons. We propose that this leads function-
ally to co-contraction or oscillatory muscle activation of flexor and extensor muscles, (including
spasms and clonus), which we observed in the open-field testing.
In conclusion, an effective treatment for spasticity should re-balance the excitatory and inhibitory
networks in the spinal cord, but also should ensure correct synaptic connectivity between extensor
and flexor muscle groups. We have shown that delayed intramuscular delivery of Neurotrophin-3 to
flexor muscles can achieve this in adulthood after bilateral pyramidotomy lesion.
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Figure 6. Spinal hyper-excitability causing hyperreflexia, spasms and disordered sensorimotor control is
normalized by intramuscular Neurotrophin-3 treatment. (A) In uninjured healthy conditions, there is a balance
between excitatory (afferent and descending) networks, pre-synaptic inhibition and motor neuron excitability. (B)
After loss of corticospinal innervation, there is a loss of specificity in connections between proprioceptive afferents,
spinal interneurons and motor neurons. Indeed, excitatory (afferent) terminations in the spinal cord are increased
Figure 6 continued on next page
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Importance of proprioceptive afferent feedback
Our findings emphasize a need to re-balance excitatory and inhibitory spinal networks and to
increase specificity of afferent connectivity in the spinal cord after CNS injury to treat sensorimotor
abnormalities and hyperreflexia. Normally, muscle spindles are involved in mediating this balancing
act by giving feedback via proprioceptive neurons. Indeed, mice lacking functional muscle spindles
(lacking proprioceptive feedback) show impaired re-organization of spinal circuitry and restricted
locomotor recovery after CNS injury (Takeoka et al., 2014; Akay et al., 2014). Muscle spindles syn-
thesize neurotrophin-3 (Copray and Brouwer, 1994) and this may be one of the feedback signals in
proprioceptive neurons underlying spontaneous recovery after spinal cord injury.
Bilateral corticospinal tract injury causes spinal cord denervation and subsequently spinal circuitry
reorganization. Corticospinal axons and proprioceptive afferents compete for synaptic space in the
spinal cord in development and also in adulthood (Jiang et al., 2016). Premotor interneurons
receive direct input from the corticospinal tract and cutaneous and proprioceptive afferent fibers
(Brownstone and Bui, 2010); following loss of corticospinal input, proprioceptive afferents may
invade the empty synaptic space on these interneurons. The synaptic space on motor neurons might
be reorganized more indirectly: bilateral pyramidotomy causes a significant loss of input to spinal
interneurons, which may then withdraw some of their input to motor neurons (i.e., anterograde
trans-neuronal synaptic loss akin to activity-based synaptic pruning in development) creating more
space for sensory afferent synapses. Our data supports this proposition. We have established that
after supraspinal injury proprioceptive afferent input reorganized and showed aberrant connection
patterns onto motor neurons in the spinal cord (Figure 6C). Intramuscular over-expression of Neuro-
trophin-3 regulated spinal circuitry re-organization and resulted in reduced sensorimotor abnormali-
ties and normalized hyperreflexia.
Did Neurotrophin-3 reduce spasticity via retrograde signaling?
Motor neurons, low threshold cutaneous mechanoceptive afferents and proprioceptive afferents
express trkC (McMahon et al., 1994), which is the main receptor for neurotrophin-3. Neurotrophins
are retrogradely transported in signaling endosomes (after they bind to and are internalized with
their receptors) (Helgren et al., 1997; Harrington et al., 2011; Sharma et al., 2010). We injected
an AAV1 expressing neurotrophin-3 into skeletal muscles, which are innervated both by propriocep-
tive afferents and motor neurons. We found increased levels of neurotrophin-3 protein in the ipsilat-
eral cervical dorsal root ganglia and in motor neurons. We can exclude transport of the AAV1 viral
vector as we did not detect the transgene of human Neurotrophin-3 in the ipsilateral cervical DRG
with qRTPCR. We also did not detect increased levels of rat neurotrophin-3 mRNA in the ipsilateral
cervical dorsal root ganglia after intramuscular injections of an AAV1 expressing the human NT3
transgene as shown by RNA sequencing (Kathe et al, unpublished). We expect that the majority of
changes in spinal cord patterning and excitability was mediated via proprioceptive afferents and
motor neurons. However, we cannot exclude the possibilities that cutaneous afferents may have
modulated spinal reflexes (Bui et al., 2013) as it is likely that skin afferents were also exposed to a
low concentration of Neurotrophin-3; or that neurotrophin-3 acted to some degree through the
Figure 6 continued
in number and there is a reduction in molecular markers of pre-synaptic inhibition upon proprioceptive afferents.
We propose that this causes increased spinal excitability. Moreover, KCC2 is internalized from the membrane of
motor neurons rendering them more excitable. Together, these result in increased spinal reflexes, hallmarks of
spasticity. (C) Injection of AAV-NT3 into flexor muscles causes trafficking of NT3 to the cervical DRG by retrograde
transport (and, possibly, to a lesser extent, by systemic transport). Treatment normalizes the pattern of
proprioceptive afferent terminations and restores pre-synaptic inhibition upon proprioceptive afferents. NT3 is
also retrogradely transported to motor neurons where KCC2 levels are normalized in the membrane. Multiple
spinal reflexes involving treated muscles are normalized. We propose that this is the result of restored specificity
of connections between proprioceptive afferents and appropriate motor neurons and normalised motor neuron
excitability. Abnormal forelimb movements including spasms are reduced and walking on the ladder is improved.
In conclusion, delayed intramuscular treatment with AAV-NT3 results in neurophysiological, molecular and
behavioural improvements after CNS injury.
DOI: 10.7554/eLife.18146.021
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vascular circulation systemically although we didn’t detect a significant increase protein in muscles
other than the injected ones or in the spinal cord. Notwithstanding our current results, systemic
delivery routes of delivery for neurotrophin-3 may be effective when higher doses of the protein are
administered, for example by intrathecal infusion after spinal cord injury (Bradbury et al., 1999,
1998). Ongoing work in our laboratory seeks to identify the optimal biopharmaceutical delivery
route and form (protein, gene therapy, agonist antibody or small synthetic molecule) for neurotro-
phin-3 and for targeting its receptors after spinal cord injury and stroke.
Mechanisms of recovery with neurotrophin-3
Neurotrophin-3 had several effects on spinal networks that likely contributed to normalization of
mono- and polysynaptic reflexes and resulted in functional recovery. Firstly, Neurotrophin-3 caused
a re-balancing of excitatory and inhibitory networks in the spinal cord. It restored the specificity and
number of excitatory boutons from proprioceptive axons onto motor neurons and a marker of pre-
synaptic inhibition to normal. Secondly, neurotrophin-3 normalised the levels of KCC2 in ulnar and
radial motor neuron membranes to normal. KCC2 subcellular location was modified either after
direct retrograde transport of neurotrophin-3 in motor axons (which might mean even the non-signif-
icant trend of increased neurotrophin-3 protein in the triceps brachii was sufficient to affect its radial
motor neurons), or it was secondary to changes in afferent or supraspinal fiber organization. Finally,
neurotrophin-3 also affected plasticity of extrapyramidal supraspinal pathways. We showed that neu-
rotrophin-3 normalized the pattern of serotonergic fibers in the cervical spinal cord. Given that other
pathways like rubrospinal tract neurons also express trkC receptors (Tetzlaff et al., 1994;
King et al., 1999) it is possible that these pathways also undergo sprouting within the cervical spinal
cord and may contribute to functional recovery (Raineteau et al., 2002).
Taken together, we propose that all these anatomical effects of neurotrophin-3 normalize spinal
reflexes and reduce spasticity that can interfere with functional recovery. This improves locomotor
function. Motor function and restoration of normal reflexes are interdependent and mutually rein-
forcing as it has been shown that neurorehabilitative training ameliorates reflexes (Coˆte´ et al., 2011)
and reflex training ameliorates neurorehabilitation (Thompson and Wolpaw, 2015).
Neurotrophin-3 is a translationally attractive therapy for treating
spasticity as part of a movement disorder
Spasticity seldom occurs in isolation, but more commonly as part of larger syndromes such as upper
motor neuron syndrome or the pyramidal syndrome associated with stroke and spinal cord injury.
These syndromes often affect other aspects of movements and sensory processing including loco-
motion, fine motor function or cutaneous sensation. Existing anti-spastic treatments, which reduce
exaggerated reflexes and muscle tone, often do not improve the movement disorder (Dietz and
Sinkjaer, 2007; Corry et al., 1997; Latash and Penn, 1996). In contrast, we have shown that neuro-
trophin-3 has the added benefit of improving other aspects of motor and sensory function after CNS
injury. Here, we have shown intramuscular treatment with neurotrophin-3 not only normalized
reflexes, but also improved locomotion and grip strength. Moreover, neurotrophin-3 treatment did
not cause detectable pain (mechanical allodynia). In previous studies, our group used delayed, intra-
muscular neurotrophin-3 to treat stroke and observed improved fine motor function and tactile sen-
sation in adult and elderly rats (Duricki et al., 2016).
Importantly, peripheral administration of neurotrophin-3 protein is safe and well-tolerated in
Phase 2 human clinical trials even with high doses (Chaudhry et al., 2000; Coulie et al., 2000;
Sahenk et al., 2005; Parkman et al., 2003; Sahenk, 2007). Our findings suggest that intramuscular
neurotrophin-3 reduces signs of spasticity and improves functional recovery by regulating spinal con-
nectivity after supraspinal injury. Moreover, a gene therapy involving intramuscular injection of an
AAV1 encoding human neurotrophin-3 under the control of a muscle-specific promoter, which was
successfully tested in a mouse model of Charcot Marie Tooth neuropathy (Sahenk et al., 2014), now
has FDA approval for a clinical trial for patients with Charcot Marie Tooth 1A (Professor Zarife
Sahenk, personal communication, August 2016). Taken together, this paves the way for neurotro-
phin-3 as a therapy for CNS injury.
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Materials and methods
Animals
All animal procedures were conducted in accordance with the UK Home Office guidelines and the
Animals (Scientific Procedures) Act of 1986. Animals were housed in groups in standard housing con-
ditions on a 12 hr light/dark cycle with food and water ad libitum. 60 female Lister hooded rats
(Charles River; outbred; 190–250 g) were used. Generally, the group size was 10 or more rats per
treatment in line with previous spinal cord injury/ stroke in vivo studies (Duricki et al., 2016;
Kathe et al., 2014). All experiments were performed in a randomized block design and blinding
during experiments and analysis was achieved by using viral vector aliquots coded by a third party.
Codes were broken at the end of the studies. Materials and methods and results have been written
in accordance with the ARRIVE guidelines for publishing in vivo research.
Pyramidotomy lesions
As described in detail previously (Kathe et al., 2014), rats were anaesthetized with 5% isoflurane in
1 L/min oxygen. The ventral neck region was shaved and swabbed with alcohol wipes. A 2 cm long
midline incision was made. Overlying tissue was blunt dissected until the trachea was exposed. The
trachea was displaced to the side and underlying muscle blunt dissected until the ventral side of the
basioccipital bone was exposed. Next, a hole was drilled. Both pyramids were cut using Vannas
microscissors and cuts were retraced with a 26-G needle. Any bleeding was stopped and the skin
was sutured. Carprieve was given as the analgesia during surgery and for the following 2 days
(5 mg/kg, subcutaneous, twice daily).
Adeno-associated viral vectors
Details of the adeno-associated viral vectors (AAV) used in these studies have been described previ-
ously (Duricki et al., 2016). In short, we used AAV plasmids encoding either human prepro-Neuro-
trophin-3 or GFP as a control treatment. The Viral Vector Core of University of Pennsylvania
packaged viral vectors into AAV1 capsids. Viruses were titer-matched for all experiments.
Muscle injections for pyramidotomy study
Muscle injections were made into the forelimb flexor muscles on the previously dominant side. 3 
1010 viral genomes of an AAV1 encoding human prepro-Neurotrophin-3 or AAV1-GFP in 90 ml PBS
containing 5% sucrose were injected with Hamilton syringes bearing 31-G needles into the dominant
forelimb at 24 hr after pyramidotomy. Rats were anaesthetized with isoflurane. The forelimb was
shaved and swabbed with alcohol wipes. An incision above the biceps brachii was made and six vol-
umes of 5 ml were injected. Another incision was made parallel to the ulnar bone. In total, eight vol-
umes of 5 ml were injected into following muscle groups: flexor carpi radialis, flexor digitorum
profundus, flexor carpi ulnaris, palmaris longus, flexor digitorum sublimis and pronator teres. The
skin was sutured. One 10 ml injection was made through the skin into the abductor digiti quinti and
one 10 ml injection was made into the plantar pad. Rats received peri-surgical Carprieve.
Muscle injections for biodistribution study
Cervical DRGs from the pyramidotomy study were used for RNA sequencing or immunohistochemis-
try (unpublished results), muscles were used for ELISA and spinal cords were used for histology (data
shown). Accordingly, a second cohort of rats were generated for evaluating the biodistribution of
NT-3 in DRG and other tissues. Rats were anaesthetized with isoflurane as previously described.
Muscle injections were aimed at the largest muscle groups in the forelimb. 3  1010 viral genomes in
90 ml PBS containing 5% sucrose were injected with Hamilton syringes bearing 31-G needles into the
triceps brachii and biceps brachii on the left side. The forelimb was shaved and swabbed with alco-
hol wipes. An incision above the biceps brachii was made and six volumes of 5 ml were injected. The
skin was sutured. Another incision was made above the triceps brachii. Twelve volumes of 5 ml were
injected into the lateral and long heads of the triceps. The skin was sutured. Animals received pre-
surgical analgesia. They were sacrificed at either 4 days or 4 weeks post-surgery.
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Tracing
Three days prior to terminal electrophysiology experiments, we retrogradely traced ulnar (flexor)
and radial (extensor) motor neurons. Rats were anaesthetized and the axilla on the treated side was
shaved and swabbed with alcohol. A cut was made over the lateral end of the pectoralis major. Skin
and overlying muscle were blunt dissected until the ulnar, median and radial nerves were visible. 2 ml
of 1% Cholera Toxin beta subunit (CTb, List Biological Laboratories) in 0.9% saline and 2 ml of 1%
Fast Blue (Sigma) in 0.9% saline (Fresenius Kabi, Cheshire, UK) were injected with a 34-G needle on
a Hamilton syringe into the ulnar and radial nerves respectively. Overlying skin was sutured and anal-
gesia was given.
Behavioural testing
Rats were trained for 3 weeks pre-surgery and then assessed fortnightly post-surgery. Based on the
Montoya staircase pellet-reaching test the dominant forepaw was determined prior to pyramidot-
omy. All behavioural testing was done by an observer blinded to treatment group.
Montoya staircase pellet reaching test
Rats were initially food-restricted to 15 g per rat overnight during the pre-training phase, but not
during testing. The staircase was filled with 3 sucrose pellets (45 mg) into each well of the 7 stairs on
either side, totaling 21 pellets per side. Rats were left for 15 min in the Montoya staircase. The total
number of eaten and displaced sucrose pellets was counted for each forelimb separately.
Horizontal ladder test
Rats crossed a 1 m long horizontal ladder with randomly spaced rungs three times. Videos of the
runs were analysed at a later time-point and errors were counted for the affected forelimb. Error val-
ues are represented as a percentage of total steps per limb.
Grip strength test
Grip strength was assessed with a bilateral grip strength device (Linton) which measures grip
strength of each arm separately and simultaneously. The grip strength device measures the force
with which rats held onto the two bars (each containing an independent force transducer) while
being gently pulled away. During each fortnightly testing session, rats were tested 4 times. The four
values for each limb were averaged to give the test scores per animal at each time.
Automated von Frey test
Rats were placed in Plexiglas boxes with a gridded floor. They were left to settle for at least 30 min
before testing started. Nociceptive responses to mechanical stimulation of the plantar surface of the
forepaws was assessed with the automated dynamic plantar aesthesiometer (37400–001, Ugo
Basile), max force 50 g, ramp duration 20 s. Each forepaw was tested separately 3 times at each
time-point. The values were averaged to give the test scores per rat at each time point.
Open-field test: scoring for spasticity and disordered sensorimotor
control of the forelimb
Rats were placed into a 50 cm diameter Plexiglas cylinder and videotaped for 3 min fortnightly. Vid-
eos were scored by a blinded observer using the Scoring sheet shown in Figure 1—figure supple-
ment 2.
Examples of each sign of spasticity and sensorimotor abnormality that was scored are shown in
Video 2. For purposes of comparison, Video 1 shows a normal rat exhibiting none of these signs.
Each forelimb was scored separately, and scores were added up to give a total score per rat (yield-
ing a maximum of 24). Other signs of spasticity (especially those relating to the hindlimb and tail)
were not scored (Video 3). The following signs of spasticity or sensorimotor abnormality were
scored, using the operational definitions given:
1. Forepaw digit flexion during swing phase. A score of 1 was given if the forepaw digits were
held in a fully flexed position during the swing phase. A score of 0 was given if the forepaw
digits appeared flaccid or atonic (i.e., neither flexed nor extended). A score of 0 was given if
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the forepaw digits were extended. The score was based on the digit position most frequently
observed during the three minutes.
2. Joint movements during swing phase. Movements of the wrist, elbow and shoulder were
assessed during the swing phase. A score was given to each joint (with a maximum score of 2
per joint). 1 point was given if the joint appeared rigid or showed corrective movement (alter-
nating trajectories in the mid-swing phase) and 2 points were given if the joint appeared rigid
and showed corrective movements. A score of 0 was given if the joint movement was smooth
or flaccid. The score was based on the type of movement frequently observed for each joint
during the three minutes. The maximum score a single forelimb could reach is six (i.e., 3 joints
 2 points).
3. Stance width: A ’Normal stance’ was defined as how the forepaw was placed by normal rats (i.
e., slightly medial to shoulders) and was given a score of 0. A ’Wide stance’ was defined as
when the forepaw was placed more laterally than that seen in normal rats. A wide stance is
often seen in rats with neurological injury because this compensatory strategy improves stabil-
ity. A score of zero was given for a wide stance because it does not indicate increased tone of
flexor muscles. A ’Narrow stance’ was defined as when the forepaw was placed more medially
than that seen in normal rats, with forepaws aligned rostrocaudally or crossed. A narrow stance
was given a score of one because it indicates increased muscle tone of flexor muscles. The
score was based on the type of stance most frequently observed during the three minutes.
4. Forelimb movements during the loading response of the stance phase. A score of 0 was given
for a normal loading response during the stance phase. A score of 1 was given for ’Repeated
muscle jerks during onset of stance’. This was defined as when, during the loading response of
the stance phase, the forelimb made contact but then withdrew immediately (with one or
more cycles of this ’bounce’). A score of 0 was given if the plantar surface of the forepaw was
not placed down during the loading response of the stance phase (’No plantar stance’), i.e.
dorsal stepping. The score was based on which of these was observed most frequently during
the three minutes.
5. Other signs of sensorimotor abnormality: prolonged muscle contractions, single and repeated
muscle jerks. A prolonged muscle contraction was defined as a longer than 2 s ’on’ muscle
activation (e.g., flexor or extensor). A single muscle jerk was defined as a rapid, single ’on-off’
muscle activation. A repeated muscle jerk was defined as a rapid and repeated ’on-off’ muscle
activation (other than in the loading response of the stance phase, to avoid double counting).
A score of 1 was given for each of these behaviours if they were observed at least once.
Many of these signs of sensorimotor abnormalities have been observed in non-human primates
(macaque monkeys) after bilateral pyramidotomy, including (1) narrower stance of forelimbs during
quadrupedal walking (Supp Video 6 of (Lemon et al., 2012), (2) dampened oscillatory movements
during forelimb movements (Supp Video 2 and 8 of [Lemon et al., 2012]) and (3) prolonged flexor
muscle contractions in sitting positions (Supp Video 7 of [Lemon et al., 2012]).
Hoffmann-reflex testing
The H-reflex was assessed at baseline and every two weeks post-surgery. Rats were anaesthetized
with 30 mg/kg ketamine and 0.1 mg/kg medetomidine. Two 24-G needle electrodes were inserted
across the medial plantar side of the wrist to stimulate the ulnar nerve (via a constant current isolated
pulse stimulator, stimulus width 100 ms, Neurolog, Digitimer). Two recording electrodes were
inserted into the abductor digiti quinti to record electromyograms. The signal was amplified (4000-
fold), filtered (with a pass band of 300 Hz to 6 kHz), digitized via PowerLab, visualized and analysed
with LabChart. The M-wave is evoked by excitation of motor axons. The H-wave is a short latency
reflex which includes monosynaptic connections: Ia proprioceptive afferents synaptically activate
motor neurons in the spinal cord (Figure 1J). The threshold (1X) was determined as the lowest stim-
ulation intensity that elicited an H-wave response in at least 75% of the recordings. First, we tested
the responses to increasing stimulus intensities at 0.1 Hz up to 2x Threshold, which activates low
threshold afferent fibers. M-wave and H-wave amplitudes were normalized to the maximum M-wave
that we recorded at higher stimulation intensities (up to a maximum threshold of 2x threshold).
Next, we tested the frequency dependent depression of the H-wave. This is also commonly referred
to as post-activation depression or as rate-dependent depression. We stimulated every 10 s with
paired stimuli at inter-stimulus intervals from 10 s to 0.1 s. The H-wave amplitude of the test stimulus
was normalized to the H-wave amplitude of the conditioning stimulus. 25 paired stimuli per fre-
quency were averaged and plotted as a frequency-depression curve. The area under the curve was
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calculated to give an H-wave measure of hyperreflexia (Figure 1—figure supplement 3F). Post-stim-
ulation, rats were given atipamezole (Antisedan, 2 mg/ml) and monitored until fully awake.
Cervical dorsal root axotomy
Three naı¨ve animals were used to confirm the H-reflex set-up. Animals were stimulated and recorded
from as stated in H-reflex methods. Immediately after the recording, six cervical dorsal roots were
cut on the stimulation/recording side. A dorsal midline incision was made above the cervical verte-
brae. Muscle tissue was blunt dissected. Laminectomies were performed from C3 to C8. The dura
was opened and dorsal roots C3 to C8 were cut with micro-scissors unilaterally. Muscle tissue was
sutured in layers and the skin was sutured. Post-surgery animals were kept anaesthetized and the
H-reflex recording protocol was repeated. After H-reflex recording, animals were sacrificed by cervi-
cal dislocation.
Terminal electrophysiology involving median, ulnar and radial nerves
Rats were anaesthetized with an intraperitoneal injection of 30 mg/kg ketamine and 0.1 mg/kg
medetomidine. A skin cut overlying the pectoralis major from the axilla to the elbow was made and
a mineral oil pool was established with the skin flaps. The brachial plexus was exposed and connec-
tive tissue was removed from the ulnar, median and radial nerves, which were cut distally. We per-
formed whole nerve recordings from the ulnar nerve, which was mounted on silver-wire hook
electrodes (Bosch et al., 2012). The median and radial nerves were stimulated to elicit a synergistic
and antagonistic response respectively (100 ms, 0.1 Hz, 0–400 mA). Stimulation intensities were cho-
sen based on the previous observations in our laboratory (Bosch et al., 2012). Alternatively, the
radial nerve was recorded from whilst stimulating the ulnar nerve. The signal was amplified (4000-
fold), filtered (with a pass band of 600 Hz to 3 kHz), digitized via PowerLab, visualized and analysed
with LabChart. Filtered traces were analysed by measuring the absolute integral (area under the rec-
tified curve) from 1.5 ms to 3.5 ms for monosynaptic responses and 3.5 ms to 12 ms for polysynaptic
responses. Values were averaged across 10 recordings per stimulation intensity per animal.
Tissue preparation
Immediately after the nerve prep, rats were perfused transcardially with PBS pH 7.4 and tissues were
dissected rapidly. Tissue for sectioning on the cryostat was post-fixed by immersion in 4% parafor-
maldehyde in PBS pH 7.4 overnight and cryoprotected in 30% sucrose in PBS pH 7.4. Tissue was fro-
zen and embedded in O.C.T., spinal cords and DRGs were sectioned transversely at 30 mm or 10 mm
thickness respectively. Tissues for protein analysis and for RNA extraction were snap-frozen in liquid
nitrogen after dissection and then stored in a  80˚C freezer. Detailed protocols for histochemistry,
immunohistochemistry, protein analysis, RNA extraction, and qRTPCR and analysis can be found
below.
Histochemistry and immunohistochemistry
Eriochrome cyanine staining was performed as described previously (James et al., 2011) using 3
sections per rat. In summary, slides were immersed in PBS pH 7.4 for 5 min, then dehydrated in a
graded ethanol series for 5 min each. Sections were cleared in Histochoice or Xylene for 15 min
before rehydrated in a graded ethanol series. Slides were washed for 5 min in distilled water before
stained in 0.16% Eriochrome Cyanine R (Sigma-Aldrich, Fluka 32752), 0.5% sulphuric acid (Sigma
84728) and 0.4% iron chloride (Alfa Aesar 12357) in dH20 for 10 min to visualize myelin. Slides were
washed in distilled water twice for 5 min and then differentiated in 0.5% aqueous ammonium
hydroxide until desired staining intensity is reached, but no more than 2 min. Slides were washed
twice for 5 min in distilled water and then dehydrated in a graded ethanol series. Finally, slides were
left in Histochoice for 10 min or longer before cover-slipping with DPX.
Immunohistochemistry was performed with following standard protocol: Tissue was blocked in
10% bovine albumin serum (Sigma, A3059) in PBS for 1 hr, then incubated with the relevant primary
antibody (Antibody Table) overnight at room temperature. After 4 washes with PBS, the appropriate
secondary antibody (Antibody Table) was applied for 90 min at room temperature. Images were
taken with a Zeiss Imager Z.1 fitted with an AxioCamMRm or with an LSM 710 microscope (Carl
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Zeiss, 0.3 mm thick optical sections). Generally, no GFP expression was observed in unstained sec-
tions of DRG or spinal cord.
All antibodies were verified by their manufacturer (Antibody Table). The serotonin antibody was
raised in rabbit and specific staining is inhibited by pre-incubation of the diluted antiserum with sero-
tonin or serotonin-BSA (manufacturer’s specification). The vGAT antibody was raised against amino
acids 75–87 of rat vGAT and its specificity for mammalian vGAT was verified by demonstrating loss
of staining using KO mice by the manufacturer. The vGluT1 antibody was raised against amino acids
456–560 of rat vGluT1. Its specificity for mammalian vGluT1 was verified by demonstrating loss of
staining in KO mice by the manufacturer. The KCC2 antibody recognizes the residues 932–1043 of
the rat ortholog and is routinely evaluated by western blot in rat brain membrane preparations by
the manufacturer. The Neurotrophin-3 antibody is a synthetic peptide corresponding to the human
prepro-Neurotrophin-3 amino acids 174- 189 (the epitope is part of the mature peptide sequence).
Staining can be inhibited with Neurotrophin-3 peptide (manufacturer’s specification).
Antibody Supplier and cat number Concentration
Rabbit anti-serotonin Sigma, S5545 1:6000
Mouse anti-vGAT Synaptic Systems 131 011 1:200 (+0.1%TX-100)
Rabbit anti-vGluT1 Synaptic Systems 135 302 1:1000 (+0.1%TX-100)
Goat- anti-CTb List Laboratories 703 1:2000
Rabbit anti-KCC2 Millipore 07-432 1:500
Rabbit anti-NT3 Abcam 65804 1:500
Alexa 488 donkey anti-mouse Life Technologies A21202 1:1000
Alexa 488 donkey anti-rabbit Life Technologies A21206 1:1000
Alexa 594 goat anti-rabbit Life Technologies A11012 1:1000
Alexa 488 donkey anti-goat Life Technologies A11055 1:1000
DyLight 650 donkey anti-goat Abcam ab96938 1:1000
Antibody table: Table showing primary and secondary antibodies.
Image analysis
Image analysis was performed with Image J or Zen Imaging software.
Analysis of serotonin immunohistochemistry
Images were acquired with a Zeiss Imager Z.1 fitted with an AxioCamMRm. Pixel intensities were
measured for each animal individually, normalized to an unstained area in the white matter and then
statistically analysed (Grider et al., 2006). The following areas were measured for serotonin immuno-
histochemistry: Laminae I-III and the ventral horn (laminae VII to IX) on the affected side. For each
area, three C8 sections per animal were analysed and then averaged.
Analysis of KCC2 ion symporter levels in ulnar and radial motor neuron
membranes
Retrogradely traced ulnar and radial motor neurons were analysed separately with immunohis-
tochemistry with an antibody against KCC2. C7/8 spinal sections were analysed. Once motor neu-
rons were identified, 3 cross-sectional lines were drawn across the motor neurons and pixel
intensities were measured along the lines. The area under the curve, where the lines cross the mem-
brane, was measured. Thus, 6 values for each motor neuron were measured, which were averaged
before further analysis. 25 motor neurons were analysed per rat and per motor neuron type.
Analysis of synaptic boutons by confocal fluorescence microscopy
To determine the number of boutons in close proximity to motor neurons or other boutons, conse-
cutive confocal images (0.3 mm thick optical sections) were acquired as z-stacks (total average thick-
ness: 15 mm) using a 63x objective. Z-stacks were analysed by scrolling through the different optical
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sections. To identify inhibitory boutons in close proximity to terminals, immunohistochemistry was
performed with antibodies for a pre-synaptic marker for GABAergic synapses (vGAT+) and a pre-
synaptic marker labeling proprioceptive or cutaneous sensory afferents terminals (vGluT1+). 250
vGluT1 boutons were scored in the ventral horn for each animal by a single and blinded experi-
menter: either the bouton was in very close proximity to at least one vGAT bouton (score = 1) (e.g.,
identified by yellow pixels in 15 mm z-stacks when projected into a single plane; see Figure 4H,J) or
not in close proximity to any vGAT boutons (score = 0) (see Figure 4I). To identify boutons in close
proximity to motor neurons, vGluT1 and vGAT boutons were counted on at least 25 motor neurons
per animal, which had been retrogradely traced with CTb or Fast Blue (see above). The average
number of vGluT1 boutons in close proximity to ulnar and radial motor neurons was calculated sepa-
rately. In each case the mean score was calculated for each rat.
Enzyme-linked-immunosorbent assay
Fresh tissue samples were immediately snap-frozen in liquid nitrogen and then stored in a  80˚C
freezer. Protein was extracted with RIPA buffer (50 mM Tris HCl pH 7.5, 150 mM NaCl, 2 mM EDTA,
1% Triton X-100, 0.1% SDS) and a hand-held mechanical homogenizer. After 1 hr incubation time,
samples were spun at 17,900 g at 4˚C for 15 min. The supernatant was collected and stored at
 20˚C. Blood samples were allowed to clot at room temperature for up to 1 hr and then centrifuged
at 17,900 g at 4˚C for 15 min. The serum was collected and stored at  20˚C. ELISAs were performed
with the Human NT-3 DuoSet kit (DY267, R&D systems) according to manufacturer’s instructions
with some modifications. In summary, plates were pre-coated with the capture antibody at room
temperature overnight. Plates were washed three times with the wash buffer and then blocked with
the reagent buffer for one hour. The washing step was repeated and 100 ml samples were applied
undiluted in duplicates. Plates were left to incubate on a shaker at room temperature for 5 hr. Post-
incubation, plates were washed and the detection antibody was applied for overnight at 4˚C. The
next day, plates were washed and streptavidin was added to each well for 20 min. The washing step
was repeated and the substrate solution applied for 20 min. The reaction was stopped with 1N
H2SO4 after which the optical density of the plate was read with a micro-plate reader at 540 nm and
450 nm (Spectramax 340PC). Concentrations were calculated with the help of a standard curve on a
four-parameter logistic curve fit. Neurotrophin-3 concentrations were normalized to the total protein
amount determined with the Bicinchoninic Assay (Millipore 71285–3) and then expressed relative to
naı¨ve control levels.
Total RNA extraction and qRTPCR
Total RNA was extracted from the C7 DRG from the rats according to the manufacturer’s instruc-
tions (Qiagen, 74104). Samples were also DNase I-treated (Qiagen, 79254). 110 ng of total RNA per
sample was used for reverse transcription to obtain the cDNA (Invitrogen, 18080–0440–044) using
random primers. We used following primer pairs for quantitative real-time PCR which was performed
in triplicates (Roche, LightCycler 480 II): human Neurotrophin-3 forward: 5’ -GAA-ACG-CGA-TGT-
AAG-GAA-GC-3’; human Neurotrophin-3 reverse: 5’- CCA-GCC-CAC-GAG-TTT-ATT-GT-3’; GAPDH
forward: 5’-ATG-GGA-AGC-TGG-TCA-TCA-AC-3’; GAPDH reverse: 5’-CCA-CAG-TCT-TCT-GAG-
TGG-CA-3’. A standard curve for human Neurotrophin-3 was obtained using threefold dilutions of
human fetal brain cDNA (Stratagene) applied in duplicate/triplicate. A standard curve for rat GAPDH
was obtained using threefold dilutions of cDNA derived from a pool of embryonic day 16–18 rat
brains. NT-3 concentrations were normalized to GAPDH levels.
Statistics
All results are expressed as mean ± Standard Error of Mean (SEM). All data points were analysed
with appropriate parametric tests as stated in figure legends. Outliers were included. The experi-
mental unit (n) was the rat. Generally, behavioural tests and frequency-dependent depression were
analysed by comparing between groups using two-way repeated measures ANOVA (group or
group*time interactions are given in Figure Legends). In the Figure Legends to
Figure 1 and Figure 3 statistical analyses are based on all groups (i.e., naı¨ve, bPYX GFP and bPYX
NT3). Eriochrome cyanine and ELISA data were analysed by comparing between groups (naı¨ve,
bPYX GFP or bPYX NT3) and sides (ipsilateral vs contralateral) using two way ANOVA (group or
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group*side interactions are given in Figure Legends). ELISA data for liver were analysed by an
unpaired t-test. The threshold for significance was p<0.05. Statistical analysis was performed in SPSS
v.19 or GraphPad Prism v.6.
Ethical approval
All animal work was done in accordance with the United Kingdom Animals (Scientific Procedures)
Act of 1986 and was approved by the Animal Welfare and Ethical Review Body (AWERB) of King’s
College London. The work was conducted under Home Office Project License number 70/7865.
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